InsiderClue
Insiders · Profile

Wein Matthew

See Remarks at Metagenomi Therapeutics. Filing since 5 Mar 2025. CIK 0002009713

Company
Date
Role
Action
Shares
Amount
Of holding
MGX Metagenomi Therapeutics, Inc.
8 Sep 2026
See Remarks
Sold at will
358
$414.71
0.3%
MGX Metagenomi Therapeutics, Inc.
5 Jun 2026
See Remarks
Sold at will
558
$724.84
0.4%
MGX Metagenomi Therapeutics, Inc.
5 Mar 2026
See Remarks
Sold at will
482
$771.20
0.4%
MGX Metagenomi Therapeutics, Inc.
5 Dec 2025
See Remarks
Sold at will
199
$352.61
0.2%
MGX Metagenomi Therapeutics, Inc.
5 Sep 2025
See Remarks
Sold at will
199
$360.19
1.0%
MGX Metagenomi Therapeutics, Inc.
6 Jun 2025
See Remarks
Sold at will
199
$348.25
1.2%
MGX Metagenomi Therapeutics, Inc.
5 Mar 2025
See Remarks
Sold at will
930
$1.74K
8.9%
7 decisions on file.